Trial intelligence / Profile preview

Prophylactic H1 and H2 Blockers for Protamine-Induced Hypotension in Cardiac Surgery

NCT03583567Phase 4Completed

Sponsor
Mahidol University
Start
Sep 2018
Primary completion
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of chlorpheniramine, ranitidine in Protamine adverse reaction, sponsored by Mahidol University. Started Sep 2018; status: completed.

02

Drugs

chlorpheniramineranitidine
03

Conditions

Protamine adverse reaction

Beyond the preview

Go deeper on NCT03583567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03583567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call